Seminars in Perinatology
Volume 33, Issue 2 , Pages 124-127 , April 2009

Transfusion Therapy in Postpartum Hemorrhage

  • Anand Padmanabhan, MD, PhD
    • ,
  • Joseph Schwartz, MD
    • ,
  • Steven L. Spitalnik, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Steven L. Spitalnik, MD, Department of Pathology and Cell Biology, Columbia University Medical Center, College of Physicians and Surgeons of Columbia University, 630 W 168th Street, New York, NY 10032

References 

  1. AbouZahr C. Safe motherhood: A brief history of the global movement 1947-2002. Br Med Bull. 2003;67:13–25
  2. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemorrhage. Obstet Gynecol. 2006;108:1039–1047
  3. Shevell T, Malone FD. Management of obstetric hemorrhage. Semin Perinatol. 2003;27:86–104
  4. Franchini M. Haemostasis and pregnancy. Thromb Haemost. 2006;95:401–413
  5. Lockwood CJ. Regulation of plasminogen activator inhibitor 1 expression by interaction of epidermal growth factor with progestin during decidualization of human endometrial stromal cells. Am J Obstet Gynecol. 2001;184:798–804discussion 804-795
  6. Lockwood CJ, Krikun G, Schatz F. The decidua regulates hemostasis in human endometrium. Semin Reprod Endocrinol. 1999;17:45–51
  7. Lockwood CJ, Schatz F. A biological model for the regulation of peri-implantational hemostasis and menstruation. J Soc Gynecol Investig. 1996;3:159–165
  8. ACOG Educational Bulletin: Postpartum Hemorrhage. Number 243, January 1998 (replaces No. 143, July 1990). American College of Obstetricians and Gynecologists Int J Gynaecol Obstet. 1998;61:79–86
  9. Combs CA, Murphy EL, Laros RK. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol. 1991;77:69–76
  10. Bonnar J. Massive obstetric haemorrhage. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000;14:1–18
  11. Murphy MF, Wallington TB, Kelsey P, et al. Guidelines for the clinical use of red cell transfusions. Br J Haematol. 2001;113:24–31
  12. Petersen LA, Lindner DS, Kleiber CM, et al. Factors that predict low hematocrit levels in the postpartum patient after vaginal delivery. Am J Obstet Gynecol. 2002;186:737–744
  13. Weiskopf RB, Viele MK, Feiner J, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA. 1998;279:217–221
  14. Platelet transfusion therapy. National Institutes of Health Consensus Conference Transfus Med Rev. 1987;1:195–200
  15. Hellstern P, Haubelt H. Indications for plasma in massive transfusion. Thromb Res. 2002;107(suppl 1):S19–S22
  16. AuBuchon J. Hemotherapy decisions and their outcomes. In:  Roback JD,  Combs MR,  Grossman BJ,  Hillyer CD editor. Technical Manual. (Ed 16). Bethesda, MD: AABB; 2008;p. 569–624
  17. Faringer PD, Mullins RJ, Johnson RL, et al. Blood component supplementation during massive transfusion of AS-1 red cells in trauma patients. J Trauma. 1993;34:481–485
  18. Hiippala S. Replacement of massive blood loss. Vox Sang. 1998;74(suppl 2):399–407
  19. Hirshberg A, Dugas M, Banez EI, et al. Minimizing dilutional coagulopathy in exsanguinating hemorrhage: A computer simulation. J Trauma. 2003;54:454–463
  20. Lundsgaard-Hansen P. Treatment of acute blood loss. Vox Sang. 1992;63:241–246
  21. Smetannikov Y, Hopkins D. Intraoperative bleeding: A mathematical model for minimizing hemoglobin loss. Transfusion. 1996;36:832–835
  22. Ho AM, Dion PW, Cheng CA, et al. A mathematical model for fresh frozen plasma transfusion strategies during major trauma resuscitation with ongoing hemorrhage. Can J Surg. 2005;48:470–478
  23. Stinger HK, Spinella PC, Perkins JG, et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma. 2008;64:S79–S85discussion S85
  24. Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma. 2007;63:805–813
  25. Engstrom M, Schott U, Romner B, et al. Acidosis impairs the coagulation: A thromboelastographic study. J Trauma. 2006;61:624–628
  26. Cosgriff N, Moore EE, Sauaia A, et al. Predicting life-threatening coagulopathy in the massively transfused trauma patient: Hypothermia and acidoses revisited. J Trauma. 1997;42:857–861discussion 861-862
  27. DeLoughery TG. Coagulation defects in trauma patients: Etiology, recognition, and therapy. Crit Care Clin. 2004;20:13–24
  28. Ferrara A, MacArthur JD, Wright HK, et al. Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion. Am J Surg. 1990;160:515–518
  29. Weiner CP. The obstetric patient and disseminated intravascular coagulation. Clin Perinatol. 1986;13:705–717
  30. Levi M. Disseminated intravascular coagulation. Crit Care Med. 2007;35:2191–2195
  31. Levi M, de Jonge E, van der Poll T. Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation. Crit Care Med. 2001;29:S90–S94
  32. Levi M, van der Poll T, ten Cate H, et al. The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur J Clin Invest. 1997;27:3–9
  33. Levi M, de Jonge E, van der Poll T, et al. Disseminated intravascular coagulation. Thromb Haemost. 1999;82:695–705
  34. Bakhtiari K, Meijers JC, de Jonge E, et al. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med. 2004;32:2416–2421
  35. Dempfle CE, Wurst M, Smolinski M, et al. Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score. Thromb Haemost. 2004;91:812–818
  36. http://www.novomedlink.com/products/NovoSeven-RT/novoseven-rt-home.aspxAccessed December 26, 2008
  37. Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127–2137
  38. Beekley AC. Damage control resuscitation: A sensible approach to the exsanguinating surgical patient. Crit Care Med. 2008;36:S267–S274
  39. Moscardo F, Perez F, de la Rubia J, et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol. 2001;114:174–176
  40. Bouwmeester FW, Jonkhoff AR, Verheijen RH, et al. Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII. Obstet Gynecol. 2003;101:1174–1176
  41. Price G, Kaplan J, Skowronski G. Use of recombinant factor VIIa to treat life-threatening non-surgical bleeding in a post-partum patient. Br J Anaesth. 2004;93:298–300
  42. Ahonen J, Jokela R. Recombinant factor VIIa for life-threatening post-partum haemorrhage. Br J Anaesth. 2005;94:592–595
  43. Haynes J, Laffan M, Plaat F. Use of recombinant activated factor VII in massive obstetric haemorrhage. Int J Obstet Anesth. 2007;16:40–49
  44. Franchini M, Lippi G, Franchi M. The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage. Br J Obstet Gynaecol. 2007;114:8–15
  45. Prosper SC, Goudge CS, Lupo VR. Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism. Obstet Gynecol. 2007;109:524–525
  46. Hedner U. Factor VIIa and its potential therapeutic use in bleeding-associated pathologies. Thromb Haemost. 2008;100:557–562
  47. Viuff D, Lauritzen B, Pusateri AE, et al. Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven). Br J Anaesth. 2008;101:324–331
  48. Hall K, Forrest P, Sawyer C. The effects of acidosis and hypothermia on blood transfusion requirements following factor VII administration. Anaesthesiol Intens Care. 2007;35:494–497
  49. Rizoli SB, Nascimento B, Osman F, et al. Recombinant activated coagulation factor VII and bleeding trauma patients. J Trauma. 2006;61:1419–1425
  50. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: Twenty-year analysis. Am J Obstet Gynecol. 2005;192:1458–1461
  51. Hatfield JL, Brumsted JR, Cooper BC. Conservative treatment of placenta accreta. J Minim Invasive Gynecol. 2006;13:510–513
  52. Kruskall MS, Leonard S, Klapholz H. Autologous blood donation during pregnancy: Analysis of safety and blood use. Obstet Gynecol. 1987;70:938–941
  53. Herbert WN, Owen HG, Collins ML. Autologous blood storage in obstetrics. Obstet Gynecol. 1988;72:166–170
  54. Monk TG. Acute normovolemic hemodilution. Anesthesiol Clin North Am. 2005;23:271–281vi
  55. Hudon L, Belfort MA, Broome DR. Diagnosis and management of placenta percreta: A review. Obstet Gynecol Surv. 1998;53:509–517
  56. Rebarber A, Lonser R, Jackson S, et al. The safety of intraoperative autologous blood collection and autotransfusion during Cesarian section. Am J Obstet Gynecol. 1998;179:715–720
  57. Gyamfi C, Gyamfi MM, Berkowitz RL. Ethical and medicolegal considerations in the obstetric care of a Jehovah's witness. Obstet Gynecol. 2003;102:173–180

PII: S0146-0005(09)00003-2

doi: 10.1053/j.semperi.2009.01.002

Seminars in Perinatology
Volume 33, Issue 2 , Pages 124-127 , April 2009

Article Tools